<DOC>
	<DOC>NCT01585103</DOC>
	<brief_summary>Whether the cytosponge will be a useful non-invasive tool in evaluating patients with eosinophilic esophagitis?</brief_summary>
	<brief_title>Cytosponge Protocol IRB 11-006429</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<criteria>â€¢Adult patients between the ages of 18 and 65 with eosinophilic esophagitis including lactating or pregnant women undergoing clinically indicated endoscopy and esophageal biopsy. Patients for whom clinically indicated endoscopy is not safe. Patients who have small caliber esophagus, an esophageal stricture that will not permit passage of the gelatin capsule or are unable to swallow the capsule. Vulnerable populations, such as those with diminished mental acuity, will be excluded. Patients with known Lidocaine/Acetylcysteine allergies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>